Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases.
about
Leukotrienes and aspirin induced asthmaThe Catalytic Architecture of Leukotriene C4 Synthase with Two Arginine ResiduesAn open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthmaNuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lungAntileukotriene agents in asthma: the dart that kills the elephant?Asthma and the Risk of Rheumatoid Arthritis: An Insight into the Heterogeneity and Phenotypes of AsthmaRole of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema.Role of LTB₄ in the pathogenesis of elastase-induced murine pulmonary emphysemaA prostacyclin analogue, iloprost, protects from bleomycin-induced pulmonary fibrosis in miceFollowing the path of CCL2 from prostaglandins to periostin in lung fibrosisPharmacotherapy of asthma in children, with special reference to leukotriene receptor antagonists.Effects of antileukotrienes in the treatment of asthma.Measurement of leukotrienes in humans.Leukotriene receptor antagonist therapyThe reproducibility and effect on non-specific airway responsiveness of inhaled prostaglandin D2 and leukotriene D4 in asthmatic subjects.Antileukotrienes in clinical development for asthma.Involvement of cysteinyl leukotrienes in airway smooth muscle cell DNA synthesis after repeated allergen exposure in sensitized Brown Norway rats.Cooperative and redundant signaling of leukotriene B4 and leukotriene D4 in human monocytes.Prostaglandin E2 and the pathogenesis of pulmonary fibrosis.Effect of the leukotriene receptor antagonist pranlukast on cellular infiltration in the bronchial mucosa of patients with asthma.Cysteinyl leukotrienes and 8-isoprostane in exhaled breath condensate of children with asthma exacerbations.Exhaled leukotrienes and prostaglandins in COPD.Gas chromatography/mass spectrometry analysis of exhaled leukotrienes in asthmatic patientsProstaglandin Transporter (PGT/SLCO2A1) Protects the Lung from Bleomycin-Induced Fibrosis.Effect of a 5-lipoxygenase inhibitor and leukotriene antagonist (PF 5901) on antigen-induced airway responses in neonatally immunized rabbits.Neutrophil chemotactic activities in bronchoalveolar lavage fluid from patients with bronchial asthma.Handle with care: targeting neutrophils in chronic obstructive pulmonary disease and severe asthma?Cigarette smoke-induced lung inflammation in COPD mediated via LTB4/BLT1/SOCS1 pathwayEffect of a leukotriene B4 receptor antagonist, LY293111, on allergen induced responses in asthma.Reduction in leukotriene B4 generation by bronchoalveolar lavage cells in asthma.A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children and adults with cystic fibrosis.Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function.Eicosanoid lipid mediators in fibrotic lung diseases: ready for prime time?Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosisBronchoalveolar lavage as a research tool.Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s.Leukotriene B4 receptor 1 is differentially expressed on peripheral T cells of steroid-sensitive and -resistant asthmatics.Opposing roles of leukotrienes and prostaglandins in fibrotic lung disease.Therapeutic progress--review XXXVII. Methotrexate--an immunomodulator with expanding indications.Eosinophil recruitment and activation: the role of lipid mediators.
P2860
Q24563001-A57AFEBA-329F-4EE7-97C4-D52C91CBDE59Q27667376-3FF048AC-BDE9-44B3-A05C-0561C430748FQ28189893-8A925645-5CC4-4F4B-A757-2184DEEDE95FQ28565050-D87D970F-5C7F-47DB-9DC4-F697FAEBBE34Q28769366-2C85218C-42B7-41AA-B765-90E3FC7B99C6Q30234766-C0E429D8-D04B-4008-BB7A-FC0217A4FBD4Q30393808-44F53839-8CFC-4490-B858-E2A7730514ABQ30429404-6F55E4CE-4D56-42B6-814A-43F3E39672E9Q33765936-BC331E14-DFD5-4B98-BBDB-D8D625E5A820Q33799756-6A892D65-A55C-46E8-9B55-A19FFCB62195Q33805187-68EA3119-DF0A-4DBA-A3E4-BF726D31A350Q33836725-604731DC-17B4-4B8F-8A32-A632B3FB2D55Q33836740-6C4E2222-EC8D-4293-B026-50B0617B49C9Q34086351-34C7E5DD-5858-430E-867F-B8D2C61B3F9AQ34346799-B29E0023-042D-4C94-8CD6-E6264C536E5DQ34481959-85BD8AC6-9D0E-4716-A380-E5BE373ED428Q35029119-0019FD8E-5A14-4226-A962-CA9FBD1EE04AQ35206683-D5E5A781-D3A5-4892-8EC3-EA2DEB5A7DDEQ35219865-DF975CF2-F057-448E-9863-A1A80CFB71B4Q35532086-5E3A995B-4EF2-42BA-B0A4-397D8CCC1BCEQ35535997-EEF784BB-6CE8-42F2-9DF9-C8098C45F18EQ35536034-A4F337BC-40D9-4824-BF7D-FCAE26D3910FQ35536727-E4EC6ACC-6ED9-4E76-A7D7-35D1FDD50FAFQ35617407-2012299C-FE7B-4F96-9AD3-24A49500BD2BQ35874712-4BF14D19-7AF6-4EF2-AFBC-29CF66A8036DQ35938813-11957109-E32F-4B9E-A746-A53A61031D2BQ36376519-24A2C259-F440-4A2A-8A2F-A00FCD02F47CQ36412757-425CC370-B6E0-4AB1-98FC-74B1503DB575Q36504441-82AB19D3-4D39-47FB-BAEE-9B651CD938EEQ36532607-DBFE677E-44F1-4D0A-BEBF-3F207F7B50C6Q36584924-66DC07A9-E745-4E5B-8B53-85CCCC681EB9Q36822323-C4151AE2-A0C5-4717-ABC9-003B1B91369DQ36970702-79F5B72E-C28C-4208-9B35-79211D68A3CDQ37354132-E5425D5F-001D-48FC-9D20-A4048F0041CFQ37504575-6E2809B1-E957-4B77-977A-805FEB89479CQ37549767-3AB39B33-3AD9-403C-B9D7-0B0AFB057524Q37634187-A9831649-1417-45C2-9B27-23DD6BB3C877Q37754750-DD381006-8B66-484F-9194-E60F37F1984AQ37924091-57E4E79D-F7CC-4581-844B-B24B4D67122BQ38092645-1E5D10CD-FE49-423F-A3E4-844809603D51
P2860
Leukotrienes, LTC4 and LTB4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Leukotrienes, LTC4 and LTB4, i ...... nd other respiratory diseases.
@en
type
label
Leukotrienes, LTC4 and LTB4, i ...... nd other respiratory diseases.
@en
prefLabel
Leukotrienes, LTC4 and LTB4, i ...... nd other respiratory diseases.
@en
P2093
P1476
Leukotrienes, LTC4 and LTB4, i ...... nd other respiratory diseases.
@en
P2093
P356
10.1016/0091-6749(89)90173-5
P407
P577
1989-07-01T00:00:00Z